Building a Medical Home for Multiply Diagnosed HIV positive Homeless Populations - Demonstration Sites Project
Page 2

Due to the transient nature of the lives of homeless people suffering from HIV, HRSA perceives that it is very much essential to strategically coordinate efforts to engage and retain these individuals in a care facility that is more than capable of meeting their unique needs as HIV patients.

In addition, the applicants of this program will have to adopt a set of organizational structures characterized as having integrated or co-located strategies for their successful service provision.

To support this, the Health Resources and Services Administration is set to administer funds in the amount of $2,400,000 to worthy applicants.

The institutions and organizations who will be deemed eligible to submit an application under this program are the following:

a) State and Local Governments

b) Academic Institutions of Higher Education

c) Local health departments

d) Community Health Centers

e) Faith-based and community-based organizations

f) Native American Tribal Governments

g) Nonprofit organizations

h) City or Township Governments

i) Special District Governments

The United States Department of Health and Human Services, the mother agency that's funding the Building a Medical Home for Multiply Diagnosed HIV positive Homeless Populations – Demonstration Sites Project, is the country's leading agency that's intended for protecting the health of all Americans and providing essential human services to all.

Building a Medical Home for Multiply Diagnosed HIV positive Homeless Populations - Demonstration Sites Project
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on grants for youth programs and home improvement grants.

Additional Resources

category - Health Grants

Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program
In this capacity, the Food and Drug Administration has recently established the Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program in an attempt to study the effects of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability.

---

Advanced Neural Prosthetics Research and Development Program
The National Institutes of Health has formed a partnership with the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to establish the Advanced Neural Prosthetics Research and Development Program.

---

Minority-Based Community Clinical Oncology Program Groups
In line with this mission, the National Institutes of Health has recently collaborated with the National Cancer Institute (NCI) in an attempt to establish the Minority-Based Community Clinical Oncology Program Groups (MBCCOP).

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---